Observation representing the patient's high-density lipoprotein (HDL) cholesterol concentration in serum or plasma.

Observation representing the patient's low-density lipoprotein (LDL) cholesterol concentration in serum or plasma, measured either directly or by calculation.

Allowed LOINC codes for LDL cholesterol measurements (direct or calculated).

Observation representing the patient's non-HDL cholesterol concentration in serum or plasma, calculated as total cholesterol minus HDL cholesterol.

Observation representing the patient's total cholesterol concentration in serum or plasma.

This profile constrains the Observation resource to represent glucose concentration in venous blood.

Lipid panel (Lipidogram) including Total Cholesterol, LDL-C, HDL-C, and Triglycerides.

Observation representing the patient's triglyceride concentration in serum or plasma, used to assess lipid metabolism and cardiovascular risk.

Observation representing Glycated Hemoglobin (HbA1c) test results in blood, reported as a percentage.

Observation representing the urine albumin-to-creatinine ratio (ACR), used to assess kidney function in diabetic patients.

Observation representing the patient's serum or plasma creatinine concentration.

LOINC codes representing eGFR measurement methos calculated using CKD-EPI formulas (original and 2021 revision).

Observation representing estimated glomerular filtration rate (eGFR) calculated using the CKD-EPI or CKD-EPI 2021 formula.

Synoptic pathology Composition with four fixed LOINC-coded sections (Pre-Analytic, Macro, Micro, Synthesis). Each top-level section and each nested subsection must carry a human-readable Narrative for clinicians, alongside references to supporting resources.

A profile on Condition for Prostate Cancer with staging for TNM and morphology.

Definition of the Observation for the Her2 receptor status

SNOMED CT procedure codes for classifying pathology diagnostic reports (cytology, histology, screening, autopsy).

Biopsy procedure performed for histopathological examination. Captures the surgical collection of tissue specimens for laboratory analysis, including biopsy type, body site, and links to collected specimens.

This profile defines how to represent an pathology orders.

This profile defines how to represent an pathology report.

Definition of the Observation for the Specimen Adequacy.

Definition of the Observation for the Specimen Measurement, which includes the physical measurements of the specimen and its number of lymph nodes.

Definition of the Observation for the Tumor Measurement

Definition of the Observation for the Tumor Observable

This profile defines how to represent Specimens in HL7 FHIR for the purpose of this guide, based on the Specimen profile from HL7 Europe with additional constraints and extensions specific to the needs of the LT Lab use case.

A profile for paraffin-embedded tissue blocks derived from a parent specimen.

This profile defines how to represent Specimen Additive Substances for the Lithuanian Laboratory IG, based on the EU Lab Substance Additive profile.

Immunohistochemical estrogen receptor (ER) status observation with expression level and percentage in tumor cell nuclei.

HER2 gene amplification molecular test observation (FISH, CISH, or SISH) with numeric HER2 average, CEP17 average, HER2/CEP17 ratio, and result classification.

Ki-67 proliferation index observation expressed as a percentage of tumor cells with positive nuclear staining.

Immunohistochemical progesterone receptor (PR) status observation with expression level and percentage in tumor cell nuclei.

Ėminį priėmęs specialistas. / Whoever has received the specimen.

Pathological regional lymph node (pN) staging for cervical cancer, AJCC 8th edition.

Pathological primary tumor (pT) staging for cervical cancer, AJCC 8th edition. Includes pTX through pT4.

Classification of HER2 gene amplification results.

HER2 immunohistochemical scoring system (0+ to 3+).

The data item records the Her2 (human epidermal growth factor receptor 2) expression status of the tumour.

Histological grade of tumor differentiation according to AJCC grading system.

Cancer morphology

Immunohistochemical expression level for receptor status (negative, weak, moderate, strong).

Microscopic finding of lymphatic and/or vascular tumor invasion.

Codes for pathology services.

Microscopic finding of perineural invasion by tumor.

Microscopic finding of tumor infiltration in periprostatic adipose tissue.

Codes for prostate tumor stages M.

Codes for prostate tumor stages N.

Codes for prostate tumor stages T.

Microscopic or Microscopic examinations of the specimen.

Microscopic finding of tumor infiltration in seminal vesicles or ejaculatory duct.

Additives used in specimen collection and processing, based on HL7 EU Laboratory specimen additive ValueSet with additional codes for Lithuanian use.

Codes for specimen adequacy.

Codes for tumor focality.

ValueSet for tumor types, coded from SNOMED CT.

Methodology used for determining tumor volume in biopsy specimens.

Peritumoral lymphovascular invasion (pLVI) 6-level classification.

Classification of HER2 gene amplification results from FISH, CISH, or SISH molecular testing.

HER2 immunohistochemical scoring system (0+ to 3+).

The data item records the Her2 (human epidermal growth factor receptor 2) expression status of the tumour.

Immunohistochemical expression level classification for receptor status assessment.

Localized Lithuanian UCUM units described as display designation and alternative code as synonym

Local codes for TumorObservableLtLab component slicing. Used until equivalent SNOMED CT observable entity codes are available.

Peritumoral lymphovascular invasion (pLVI) 6-level classification for breast cancer pathology.

Synoptic pathology composition conforming to PathologyCompositionLtLab: Pre-Analytic, Macro, Micro, and Synthesis (LOINC section codes). Entries reference breast histopathology examples for the main pathway; synthesis also references an example prostate cancer Condition to illustrate TNM and morphology staging in this guide.

Example of pathological T category with clinical N and M categories and ICD-O-3 morphology, for use alongside synoptic pathology reporting.

Example observation of a patient's urine albumin-to-creatinine ratio.

Example observation showing a patient's HDL cholesterol level within normal range.

Example observation showing a patient's calculated LDL cholesterol level.

Example observation showing a patient's non-HDL cholesterol level within normal range.

Example observation of serum creatinine concentration.

Example of laboratory glucose measurement in venous blood.

Example of HbA1c test result for a patient with moderately elevated glycemia.

Example lipid panel with high LDL and normal HDL.

Prostate Specific Antigen (PSA) Observation Example

Prostate-Specific Antigen Density (PSAD) Observation Example

Prostate Volume Observation Example

An example instance of the Specimen Measurement observation.

Example observation showing a patient's total cholesterol level within normal range.

Example observation showing a patient's triglyceride level within normal range.

An example instance of the Tumor Measurement observation.

Example showing a patient's eGFR result calculated using the CKD-EPI 2021 formula.

An example Patient conforming to the Lithuanian Base Profile.

Example of a breast biopsy procedure performed for histopathology.

Example of a histology procedure performed during pathology evaluation.

Example of the pathology order.

Example pathology order for prostate-related examination using a PathologyProcedure code (prostate neoplasm screening).

Venous blood sample used for glucose testing.